Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |